PRO788 nucleic acids

Details PRO788 nucleic acids PRO788 nucleic acids

2006-03-28

2006-03-28

Mertz, Prema (Department: 1646)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S069100, C435S320100, C435S325000, C435S471000, C435S358000, C435S252330, C435S254200

Reexamination Certificate

active

07019124

ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: WO 99/46281 (1999-09-01), None
patent: WO 01/34800 (2001-05-01), None
Eck & Wilson in Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, McGraw-Hill New York, 1996.
Sloane et al.,Biochem, J., 234(2):355-362 (1986).
Ridge and Sloane,Cytokine, 8(1):1-5 (1996).
Klein et al.,Proc. Natl. Acad. Sci., 93:7108-7113 (1996).
Blast Results A1-A6 (Alignment of DNA56405 and various nucleotide sequences—GenBank Database), Oct. 4, 2001.
Blast Results B1-B3 (Alignment of DNA56405 and various polypeptide sequences—Dayhoff Database), Oct. 3, 2001.

Affiliated with

Also associated with

Rating

PRO788 nucleic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PRO788 nucleic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRO788 nucleic acids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3575919